retatrutide safety study Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 ESC 2024: Retatrutide improves lipid

Similarly, Duperray et al

The muscle circadian rhythm promotes neutral lipid storage by brain and muscle arnt-like 1-dependent activation of DGAT2, while REV-ERB suppresses key target genes to downregulate lipid degradation and protein turnover [112]

Kaufman: The fact that nearly half of GLP-1 patients (49%) receive multimodal carewhich may include injectables, energy-based devices, and topical skincareunderscores the inherent complexity of restoring facial balance after medication-related weight loss

Patients who receive a combination of anesthetic and steroid medication may notice a slight increase in pain after the injection as the numbing medicine wears off and the cortisone starts to take effect

Celsius CEO talks new acquisition and rise of sugar-free energy drinks. CNBC